Detalhe da pesquisa
1.
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial.
Lancet Oncol
; 24(3): 273-285, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36858723
2.
Tolerability of bevacizumab and chemotherapy in a phase 3 clinical trial with human epidermal growth factor receptor 2-negative breast cancer: A trajectory analysis of adverse events.
Cancer
; 127(24): 4546-4556, 2021 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34726788
3.
Factors associated with late risks of breast cancer-specific mortality in the SEER registry.
Breast Cancer Res Treat
; 189(1): 203-212, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33893907
4.
Near Field Propulsion Forces from Nonreciprocal Media.
Phys Rev Lett
; 126(17): 170401, 2021 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33988403
5.
Correction to: Factors associated with late risks of breast cancerspecific mortality in the SEER registry.
Breast Cancer Res Treat
; 189(1): 305, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34231078
6.
Evolution of HER2 expression between pre-treatment biopsy and residual disease after neoadjuvant therapy for breast cancer.
Eur J Cancer
; 201: 113920, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38368741
7.
Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor-Positive Breast Cancer.
JAMA Oncol
; 10(4): 508-515, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38421673
8.
Importance of Low- and Moderate-Grade Adverse Events in Patients' Treatment Experience and Treatment Discontinuation: An Analysis of the E1912 Trial.
J Clin Oncol
; 42(3): 266-272, 2024 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37801678
9.
Patient-Reported Adverse Events and Early Treatment Discontinuation Among Patients With Multiple Myeloma.
JAMA Netw Open
; 7(3): e243854, 2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38536173
10.
Estimating mortality in women with triple-negative breast cancer: The 'ESTIMATE triple-negative' tool.
Eur J Cancer
; 189: 112930, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37356327
11.
Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211).
J Clin Oncol
; 41(7): 1359-1369, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36260828
12.
Inflammatory cytokines and distant recurrence in HER2-negative early breast cancer.
NPJ Breast Cancer
; 8(1): 16, 2022 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35136076
13.
Estimating long-term mortality in women with hormone receptor-positive breast cancer: The 'ESTIMATE' tool.
Eur J Cancer
; 173: 20-29, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35841843
14.
Examining allostatic load, neighborhood socioeconomic status, symptom burden and mortality in multiple myeloma patients.
Blood Cancer J
; 12(4): 53, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35365604
15.
Change in circulating proteins during treatment of pulmonary exacerbation in patients with cystic fibrosis.
Health Sci Rep
; 4(1): e246, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33614983